Windows of opportunity for Ebola virus infection treatment and vaccination.

about

High-resolution epidemic simulation using within-host infection and contact data Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus

P2860

Q56475639-4985FDA7-22D2-4505-87D5-9EB50F0DA0F1 Q56535662-D0EEB36F-5540-4EC8-BDA7-1C62EFA7ECEA

P2860

Windows of opportunity for Ebola virus infection treatment and vaccination.

Item

http://www.wikidata.org/entity/Q38615306

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Windows of opportunity for Ebola virus infection treatment and vaccination.

@en

type

Item

label

Windows of opportunity for Ebola virus infection treatment and vaccination.

@en

prefLabel

Windows of opportunity for Ebola virus infection treatment and vaccination.

@en

P1476

Windows of opportunity for Ebola virus infection treatment and vaccination.

@en

P2093

Esteban A Hernandez-Vargas

http://www.w3.org/2001/XMLSchema#string

Van Kinh Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Modeling Influenza Virus Infection: A Roadmap for Influenza Research

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

Immunobiology of Ebola and Lassa virus infections.

Ebola virus vaccines: Where do we stand?

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Influenza A virus infection kinetics: quantitative data and models.

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.

Ebola virus pathogenesis: implications for vaccines and therapies.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

P2888

s41598-017-08884-0

P304

8975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-08884-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Esteban A Hernandez-Vargas

Van Kinh Nguyen

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091255888

http://www.w3.org/2001/XMLSchema#string

P698

28827623

http://www.w3.org/2001/XMLSchema#string

P921

Ebola virus

Vaccine against Ebola

P932

5567060

http://www.w3.org/2001/XMLSchema#string

Windows of opportunity for Ebola virus infection treatment and vaccination.

about

P2860

P2860

Windows of opportunity for Ebola virus infection treatment and vaccination.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932